Tirzepen Is Proven To Help Lower A1C*

Currently, it is approved for the treatment of type 2 diabetes. It can be used in combination with other medications, like metformin, when blood sugar is not adequately controlled.

Tirzepen is administered via a subcutaneous injection once a week. It can be injected into the abdomen, thigh, or upper arm, with the injection site rotated each time​.

Treatment typically begins with a low dose, which is gradually increased as needed. There must be at least a three-day interval between doses, and it can be taken with or without food​.

The most common side effects include:

• Nausea
• Diarrhea
• Appetite loss
• Vomiting
• Constipation
• Abdominal pain These effects are typically more pronounced in the initial weeks of treatment and tend to lessen over time.

Serious side effects include:

• Pancreatitis
• Severe allergic reactions (swelling, difficulty breathing)
• Acute kidney injury, especially in those with pre-existing conditions
• Diabetic retinopathy (worsening in those with diabetes)

Tirzepen is not recommended for:

• People with type 1 diabetes
• Those under 18 years old
• Individuals with a personal or family history of medullary thyroid carcinoma (MTC)
• Those with multiple endocrine neoplasia type 2 (MEN 2)
• People allergic to the medication's ingredients​

There is insufficient data to determine the safety of Tirzepen during pregnancy or breastfeeding. If you are pregnant or planning to become pregnant, consult your doctor​

Yes, but combining it with other diabetes medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia. Your doctor may adjust the doses accordingly​

It may take up to four weeks or longer to feel the full benefits of the medication. However, it is important to continue taking it as prescribed, even if symptoms improve

If you miss a dose, take it as soon as you remember within four days. If more than four days have passed, skip the dose and resume the regular schedule. Do not take two doses within three days​

• Inform your doctor about any pre-existing conditions, especially related to the pancreas, kidneys, or vision.
• Avoid using Tirzepen if you or your family have a history of medullary thyroid cancer​

Although Tirzepen has shown promising results for weight loss, it is currently only approved for treating type 2 diabetes. Its use specifically for weight management is still pending regulatory approval

Yes, tirzepatide can alter the absorption of other orally taken medications and increase the risk of hypoglycemia when used with insulin or sulfonylureas. Be sure to inform your doctor about all medications and supplements you are taking​